Literature DB >> 22188427

Hypercalcaemia due to parathyroid carcinoma presenting in the third trimester of pregnancy.

Ryan G Paul1, Marianne S Elston, Anthony J Gill, Deborah Marsh, Ian Beer, Louise Wolmarans, John V Conaglen, Goswin Y Meyer-Rochow.   

Abstract

Primary hyperparathyroidism (pHPT) in pregnancy may be associated with significant maternal and fetal morbidity and mortality. Medical management of pHPT in pregnancy is limited, and surgery is the only definitive therapeutic option. The ideal timing for surgery is mid-second trimester, but surgery may also be safely performed in the third trimester. Delayed parathyroid surgery may result in a hypercalcaemic crisis postpartum owing to loss of active placental calcium transfer. We present a case of parathyroid carcinoma in pregnancy presenting with pre-eclampsia at 32 weeks' gestation.
© 2011 The Authors. Australian and New Zealand Journal of Obstetrics and Gynaecology © 2011 The Royal Australian and New Zealand College of Obstetricians and Gynaecologists.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22188427     DOI: 10.1111/j.1479-828X.2011.01391.x

Source DB:  PubMed          Journal:  Aust N Z J Obstet Gynaecol        ISSN: 0004-8666            Impact factor:   2.100


  4 in total

1.  Primary hyperparathyroidism in pregnancy leading to hypercalcaemic crisis and uraemic encephalopathy.

Authors:  E Nash; P Ranka; G Tarigopula; T Rashid
Journal:  BMJ Case Rep       Date:  2015-03-27

2.  Parathyroid carcinoma in pregnancy.

Authors:  Maja Baretić; Hrvojka Tomić Brzac; Margareta Dobrenić; Antonia Jakovčević
Journal:  World J Clin Cases       Date:  2014-05-16       Impact factor: 1.337

3.  Two cases of primary hyperparathyroidism in pregnancy.

Authors:  Paul Hession; Jennifer Walsh; Geraldine Gaffney
Journal:  BMJ Case Rep       Date:  2014-01-27

Review 4.  Parathyroid Disease in Pregnancy and Lactation: A Narrative Review of the Literature.

Authors:  Elena Tsourdi; Athanasios D Anastasilakis
Journal:  Biomedicines       Date:  2021-04-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.